MedTrace Logo

A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome)

NCT02875639 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2016-08-23

No results posted yet for this study

Summary

The main purpose of this research is to reveal the curative effect mechanism of Yiqihuoxue prescription which treat the disease of qi deficiency and blood stasis. And at the same time this study also try to confirm yiqi huoxue fang qi deficiency blood stasis treatment of coronary heart disease (CHD) heart failure the curative effect and security.

Conditions

  • Ischemic Heart Failure

Interventions

DRUG

Yiqi prescription

DRUG

Huoxue prescription

DRUG

Buyang huanwu decoction

DRUG

QISHEN YIQI DRIPPING PILLS

DRUG

Placebo 1

Placebo 1：a drug which imitated QISHEN YIQI DRIPPING PILLS,but do not have active ingredient,just have the excipient.

DRUG

Placebo 2

Placebo 2：a drug which imitated Buyang huanwu decoction,but do not have active ingredient,just have the excipient.

Sponsors & Collaborators

  • Zhu Mingjun

    lead OTHER

Principal Investigators

  • Zhu M jun · First affiliated hospital, Henan University of Traditional Chinese medicine

  • Wang Y xia · First affiliated hospital, Henan University of Traditional Chinese medicine

  • Li Bin · First affiliated hospital, Henan University of Traditional Chinese medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02875639 on ClinicalTrials.gov